Our data suggests a similar imbalance between cytotoxic and regulatory responses, with reduced IL-10+ T cells and increased IL-17+ T cells potentially contributing to severity, as IL-10 limits Th17-mediated pathology in experimental leishmaniasis (40). The gene discussed is IL17A; the disease is leishmaniasis.